1 active not recruiting, 1 not yet recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Not yet recruiting 1 |
Follow Digestive System Neuroendocrine Neoplasm: new trials by email Literature Review of Digestive System Neuroendocrine Neoplasm trials Research Report on Digestive System Neuroendocrine Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas Biospecimen Collection, Computed Tomography, Incomplete Freund''s Adjuvant - Digestive System Neuroendocrine Neoplasm, Lung Neuroendocrine Neoplasm | Phase 2 | Not yet recruiting | Roswell Park Cancer Institute | 60 | 2026-12-15 | 2026-10-20 |
| Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors Everolimus, Lenvatinib - Advanced Carcinoid Tumor, Digestive System Neuroendocrine Neoplasm | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 36 | 2019-07-30 | 2026-09-18 |
Adenoma, Islet Cell (1) · Multiple Endocrine Neoplasia Type 1 (1) · Neuroendocrine Tumors (1)
Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Adenoma (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Genetic Diseases, Inborn (1) · Multiple Endocrine Neoplasia (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Multiple Primary (1) · Neoplasms, Nerve Tissue (1)
Colony-Stimulating Factors (1) · Everolimus (1) · Magnetic Resonance Spectroscopy (1) · Specimen Handling (1) · Temozolomide (1) · incomplete Freund's adjuvant (1) · lenvatinib (1) · montanide ISA 51 (1) · sargramostim (1)
M.D. Anderson Cancer Center (1) · Roswell Park Cancer Institute (1)
United States (2)
Jasmeet Kaur, MD (1) · Nageshwara V Dasari (1)